The report provides a detailed analysis essential for establishing a Romidepsin production plant. It encompasses all critical aspects necessary for Romidepsin production, including the cost of Romidepsin production, Romidepsin plant cost, Romidepsin production costs, and the overall Romidepsin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Romidepsin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Romidepsin is an FDA-approved drug known for its remarkable anticancer properties. The drug is utilized for the treatment of a certain type of cancer. Moreover, it also finds its application for the e treatment of peripheral T-cell lymphoma in patients who have received at least one prior systemic therapy. Additionally, the compound is also employed as an investigational drug in research studies for the treatment of HIV infection.
The market for Romidepsin is largely driven by its application as an antineoplastic agent for the treatment of cutaneous T-cell lymphoma (CTCL), which significantly fuels its demand in the medical, pharmaceutical, and healthcare industries. Moreover, its employment as an experimental drug for research purposes and in the development of drugs for HIV infection treatment further boosts its demand in the biotechnology and research & development industries. Additionally, multiple factors, including the cost and the availability of raw material (Chromobacterium violaceum), source, purity, maintaining quality standards, and sustainability practices, remarkably influence industrial Romidepsin procurement to a large extent.
Raw Material for Romidepsin Production
According to the Romidepsin production plant project report, the major raw material for Romidepsin production includes Chromobacterium (C.) violaceum.
Production Process of Romidepsin
The extensive Romidepsin production cost report consists of the following industrial production process:
- Production via Fermentation: This method of production involves the use of a strain of soil bacterium, Chromobacterium (C.) violaceum, for the synthesis of Romidepsin as the product. In this method, cultures of the soil bacterium Chromobacterium (C.) violaceum are subjected to undergo fermentation under controlled conditions, which results in the formation of Romidepsin as the final product. Then, the obtained Romidepsin is further purified by standard chromatographic and recrystallization processes to obtain a pure form of the drug, Romidepsin.
Romidepsin is an intravenous cyclodepsipeptide drug that is sold under the brand name Istodax. The molar mass of the compound is 540.7g/mol, and its molecular formula is C24H36N4O6S2. Moreover, the density of the compound is 1.174gm/cm3, and it is stored at -20°C. Also, the melting point of the compound is 219-224°C, and the boiling point of the compound is 942.8°C. Additionally, the compound appears in the form of white to beige color powder, and it is derived from a Gram-negative bacteria, Chromobacterium violaceum. The compound has extremely low solubility in water but is somewhat soluble in organic solvents, and it is available in the form of an injection.
